Literature DB >> 17613508

Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.

D Warwick1, R J Friedman, G Agnelli, E Gil-Garay, K Johnson, G FitzGerald, F M Turibio.   

Abstract

Patients who have undergone total hip or knee replacement (THR and TKR, respectively) are at high risk of venous thromboembolism. We aimed to determine the time courses of both the incidence of venous thromboembolism and effective prophylaxis. Patients with elective primary THR and TKR were enrolled in the multi-national Global Orthopaedic Registry. Data on the incidence of venous thromboembolism and prophylaxis were collected from 6639 THR and 8326 TKR patients. The cumulative incidence of venous thromboembolism within three months of surgery was 1.7% in the THR and 2.3% in the TKR patients. The mean times to venous thromboembolism were 21.5 days (sd 22.5) for THR, and 9.7 days (sd 14.1) for TKR. It occurred after the median time to discharge in 75% of the THR and 57% of the TKA patients who developed venous thromboembolism. Of those who received recommended forms of prophylaxis, approximately one-quarter (26% of THR and 27% of TKR patients) were not receiving it seven days after surgery, the minimum duration recommended at the time of the study. The risk of venous thromboembolism extends beyond the usual period of hospitalisation, while the duration of prophylaxis is often shorter than this. Practices should be re-assessed to ensure that patients receive appropriate durations of prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613508     DOI: 10.1302/0301-620X.89B6.18844

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  57 in total

1.  Use of the WHO surgical safety checklist in trauma and orthopaedic patients.

Authors:  Mathew Sewell; Miriam Adebibe; Prakash Jayakumar; Charlie Jowett; Kin Kong; Krishna Vemulapalli; Brian Levack
Journal:  Int Orthop       Date:  2010-08-21       Impact factor: 3.075

2.  Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.

Authors:  Piotr Kasina; Alexander Wall; Lasse J Lapidus; Ola Rolfson; Johan Kärrholm; Szilard Nemes; Bengt I Eriksson; Maziar Mohaddes
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

3.  Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.

Authors:  Thomas Wilke; Jörn Moock; Sabrina Müller; Matthias Pfannkuche; Andreas Kurth
Journal:  Clin Orthop Relat Res       Date:  2010-03-24       Impact factor: 4.176

Review 4.  Anticoagulation therapy in 2015: where we are and where we are going.

Authors:  Jeffrey I Weitz
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

Review 5.  Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty.

Authors:  Richard J Friedman
Journal:  Am Health Drug Benefits       Date:  2012-03

6.  CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm?

Authors:  Michele R D'Apuzzo; Thomas C Keller; Wendy M Novicoff; James A Browne
Journal:  Clin Orthop Relat Res       Date:  2013-05-10       Impact factor: 4.176

Review 7.  The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.

Authors:  Saleh Rachidi; Ehab Saad Aldin; Charles Greenberg; Barton Sachs; Michael Streiff; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

8.  Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.

Authors:  Gary H Lyman; Laurent Eckert; Yanxin Wang; Hongwei Wang; Alexander Cohen
Journal:  Oncologist       Date:  2013-11-08

9.  Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice.

Authors:  Miodrag Filipovic; Thomas Schnider
Journal:  F1000 Med Rep       Date:  2010-05-24

10.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.

Authors:  Siân Sweetland; Jane Green; Bette Liu; Amy Berrington de González; Marianne Canonico; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.